BerGenBio

AGM Information • Dec 9, 2020

BerGenBio ASA: Extraordinary General Meeting

Bergen, Norway, 9 December 2020 – Extraordinary General Meeting in BerGenBio ASA was held virtually on 9 December 2020 at 16:00 hours (CET).

All proposals were resolved as presented in the notice convening the extraordinary general meeting distributed on 18 November 2020, as further set out in the minutes from the extraordinary general meeting attached hereto and available at https://www.bergenbio.com/investors/general- meetings/

-Ends-

For further information, please contact:

Richard Godfrey CEO, BerGenBio ASA +47 917 86 304

Rune Skeie, CFO, BerGenBio ASA rune.skeie@bergenbio.com +47 917 86 513

Forward looking statements

This announcement may contain forward-looking statements, which as such are not historical facts, but are based upon various assumptions, many of which are based, in turn, upon further assumptions. These assumptions are inherently subject to significant known and unknown risks, uncertainties and other important factors. Such risks, uncertainties, contingencies and other important factors could cause actual events to differ materially from the expectations expressed or implied in this announcement by such forward-looking statements.

This information is subject to the disclosure requirements pursuant to section 5-12 of the Norwegian Securities Trading Act.